<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated the seroepidemiology of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> due to Epstein-Barr virus (EBV) in 181 south Indian subjects aged 0-25 years using the indirect immunofluorescence method to titrate antibodies to <z:mp ids='MP_0001799'>viral</z:mp> capsid antigen (VCA), nuclear antigen (EBNA), and early antigen (EA) </plain></SENT>
<SENT sid="1" pm="."><plain>The age-specific prevalence of IgG antibodies to VCA rose rapidly to 90% by the age of 5 years </plain></SENT>
<SENT sid="2" pm="."><plain>The prevalence of VCA-specific IgM and the geometric mean titre of VCA-specific IgG antibodies were highest between the ages of 6 months and 2 years, the median age of <z:e sem="disease" ids="C0948192" disease_type="Disease or Syndrome" abbrv="">primary infection</z:e> being 1.4 years </plain></SENT>
<SENT sid="3" pm="."><plain>Thus primary <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> occurs early in life </plain></SENT>
<SENT sid="4" pm="."><plain>EA antibody prevalence was highest (55%) in the third year of life and remained between 30% and 40% thereafter </plain></SENT>
<SENT sid="5" pm="."><plain>This pattern of EA antibody prevalence suggests that the latent <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> that persists lifelong after <z:e sem="disease" ids="C0948192" disease_type="Disease or Syndrome" abbrv="">primary infection</z:e> may be reactivated in many individuals </plain></SENT>
<SENT sid="6" pm="."><plain>EBNA antibody prevalence was low until the age of 2 years but rose to 80% in the fourth year </plain></SENT>
<SENT sid="7" pm="."><plain>Geometric mean titres of antibodies to EA and EBNA were low and stable at <z:hpo ids='HP_0000001'>all</z:hpo> ages </plain></SENT>
<SENT sid="8" pm="."><plain>These results are similar to data from areas where EBV-associated Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is endemic and indicate a high <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">EBV infection</z:e> load early in life </plain></SENT>
</text></document>